4-甲氧基丁胺 | 34039-36-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 4-甲氧基丁胺
• 英文名称: 4-methoxybutan-1-amine
• 英文别名: 4-methoxybutylamine；4-methoxy-butylamine；Methyl-(δ-amino-butyl)-aether；δ-Methoxy-butylamin；4-Methoxy-butylamin；4-(methyloxy)-1-butanamine
• CAS: 34039-36-6
• 化学式: C₅H₁₃NO
• mdl: MFCD00086086
• 分子量: 103.164
• InChiKey: YUUFAJOXLZUDJG-UHFFFAOYSA-N

物化性质

• 沸点：
  115-120 °C(Press: 0.05 Torr)
• 密度：
  0.851±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  7
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2922199090

反应信息

• 作为反应物：
  描述：

  4-甲氧基丁胺 在 tris-(dibenzylideneacetone)dipalladium(0) 、 R-(+)-1,1'-联萘-2,2'-双二苯膦 盐酸 、 potassium tert-butylate 、 三甲基硅咪唑 、 N,N'-二环己基碳二亚胺 作用下， 以 二氯甲烷 、 水 、 甲苯 、 乙腈 为溶剂， 反应 69.0h， 生成 N1-(6-chloro-3'-ethyl-2-biphenylyl)-N2-methyl-N1-[4-(methyloxy)butyl]glycinamide
  参考文献：
  名称：

  WO2008/156831

  摘要：

  公开号：
• 作为产物：
  描述：

  4-甲氧基丁腈 在 lithium aluminium tetrahydride 作用下， 以 乙醚 为溶剂， 反应 1.0h， 生成 4-甲氧基丁胺
  参考文献：
  名称：

  Synthesis of Substituted 6-Anilinouracils and Their Inhibition of DNA Polymerase IIIC and Gram-Positive Bacterial Growth

  摘要：

  Certain substituted 6-anilinouracils are potent and selective inhibitors of Gram+ bacterial DNA polymerase IIIC (pol IIIC). In addition, analogues with 3-substituents in the uracil ring have potent antibacterial activity against Gram+ organisms in culture. In an attempt to find optimal anilino substituents for pol IIIC binding and optimal 3-substituents for antibacterial activity, we have prepared several series of 3-substituted-6-aminouracils and assayed their activity against pol IIIC from Bacillus subtilis and a panel of Gram+ and Gram- bacteria in culture. The 6-(3-ethyl-4-methylanilino) group and closely related substituent patterns maximized pol IIIC inhibition potency. Among a series of 3-(substituted-butyl)-6-(3-ethyl-4-methylanilino)uracils, basic amino substituents increased pol IIIC inhibition, but decreased antibacterial activity. The most potent antibacterials were simple hydroxybutyl and methoxybutyl derivatives, and hydrophobically substituted piperidinylbutyl derivatives.

  DOI：

  10.1021/jm020591z

文献信息

• Disrupting the Conserved Salt Bridge in the Trimerization of Influenza A Nucleoprotein
  作者：Jennifer L. Woodring、Shao-Hung Lu、Larissa Krasnova、Shih-Chi Wang、Jhih-Bin Chen、Chiu-Chun Chou、Yi-Chou Huang、Ting-Jen Rachel Cheng、Ying-Ta Wu、Yu-Hou Chen、Jim-Min Fang、Ming-Daw Tsai、Chi-Huey Wong

  DOI：10.1021/acs.jmedchem.9b01244

  日期：2020.1.9

  threat to public health. To develop a broad-spectrum inhibitor of influenza to combat the problem of drug resistance, we previously identified the highly conserved E339...R416 salt bridge of the nucleoprotein trimer as a target and compound 1 as an inhibitor disrupting the salt bridge with an EC50 = 2.7 μM against influenza A (A/WSN/1933). We have further modified this compound via a structure-based

  流感感染中的抗病毒药物耐药性已成为对公共卫生的主要威胁。为了开发广谱的流感抑制剂来解决耐药性问题，我们之前确定了高度保守的核蛋白三聚体E339 ... R416盐桥为靶标，化合物1为通过EC50破坏盐桥的抑制剂甲型流感病毒= 2.7μM（A / WSN / 1933）。我们通过基于结构的方法进一步修饰了该化合物，并进行了抗病毒活性筛选，以鉴定化合物29和30的EC50值分别为110和120 nM，并且没有可测量的宿主细胞毒性。与临床使用的神经氨酸酶抑制剂相比，这两种化合物对耐药性A型流感病毒株和B型流感病毒显示出更好的活性，
• Enantioselective synthesis of substituted α-aminophosphonates catalysed by <scp>d</scp>-glucose-based crown ethers: pursuit of the origin of stereoselectivity
  作者：Son Truong Pham、Zsolt Rapi、Péter Bakó、Imre Petneházy、András Stirling、Zsuzsa Jászay

  DOI：10.1039/c7nj03345a

  日期：——

  N-protected aminomethylenephosphonate onto acrylic acid derivatives and trans-β-nitrostyrene. Among these crown ethers, three are new. Michael adducts were formed with good to excellent enantio- and diastereoselectivities. Combined MM and QM calculations have revealed that suitable side arms on the crown ether beneficially affect the position of the central sodium cation, which in turn helps enhance the stereocontrol

  将几种与苯基-β- D-吡喃葡萄糖苷退火的单氮杂-15-冠-5型大环化合物用作手性催化剂，用于将N-保护的氨基亚甲基膦酸酯对映体选择性加成到丙烯酸衍生物和反式-β-硝基苯乙烯上。在这些冠醚中，有三个是新的。迈克尔加合物形成的对映选择性和非对映选择性都很好。MM和QM的组合计算表明，冠醚上合适的侧臂有利地影响了中央钠阳离子的位置，进而通过允许底物与催化剂之间的紧密接触，有助于增强立体控制。
• [EN] 6-(5-HYDROXY-1H-PYRAZOL-1-YL)NICOTINAMIDE DERIVATIVES AND THEIR USE AS PHD INHIBITORS<br/>[FR] INHIBITEURS 6-(5-HYDROXY-1H-PYRAZOL-1-YL)NICOTINAMIDE DE PHD
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2014160810A1

  公开（公告）日：2014-10-02

  The present invention provides compounds of formula (I) which are useful as inhibitors of PHD, pharmaceutical compositions thereof, methods for treatment of conditions associated with HIF, processes for making the compounds and intermediates thereof.

  本发明提供了公式(I)的化合物，这些化合物可用作PHD的抑制剂，以及与HIF相关疾病的治疗方法，制备这些化合物及其中间体的药物组合物。
• 6, 9-disubstituted 2-&lsqb;trans-(4-aminocyclohexyl)amino&rsqb; purines
  申请人：Aventis Pharmaceuticals Inc.

  公开号：US06479487B1

  公开（公告）日：2002-11-12

  The present invention provides novel compounds of the formula (I) wherein R is selected from the group consisting of R2, R2NH—, or R3R4N—R5- wherein R2 is selected from the group consisting of C9-C12 alkyl, Z is selected from the group consisting of phenyl, heterocycle, cycloalkyl, and naphthanlene; and M is selected from the group consisting of hydrogen, C1-C4 alkyl, and wherein each C9-C12 alkyl or Z is optionally substituted with 1 to 3 substituents, which may be the same or different, and which are selected from the group consisting of D, E, wherein each D is independently selected from the group consisting of trifluoromethyl, trifluoromethoxy, and C1-C4 alkoxy; each E is independently selected from the group consisting of Hal, OH, and C1-C8 alkyl; R3 and R4 are selected from the group consisting of hydrogen, C1-C4 alkyl and (CH2)y-phenyl, wherein y is an integer 0-8, with the proviso that R3 and R4 not both be hydrogen; R5 is C1-C8 alkylene; and R1 is selected from the group consisting of cyclopentyl, cyclopentenyl and isopropyl, and the pharmaceutically acceptable salts, optical isomers, and hydrates thereof, with the proviso that when R2 is the group wherein n is 1 or greater; R1 is isopropyl or cyclopentyl; R6 is hydrogen, C1-C4 alkyl, or (CH2)m-phenyl; and Z is phenyl, heterocycle, or cycloalkyl, that Z is substituted with 1 to 3 substituents, which may be the same or different, and which are selected from the group consisting of In addition, the present invention provides a method of inhibiting cyclin dependent kinases, particularly cdk-2. The present invention also provides a method of preventing apoptosis in neuronal cells and a method of inhibiting the development of neoplasms.

  本发明提供了一种新型化合物，其化学式为（I），其中R选自由R2、R2NH—或R3R4N—组成的群，其中R2选自由C9-C12烷基组成的群，Z选自由苯基、杂环、环烷基和萘基组成的群；M选自由氢、C1-C4烷基，其中每个C9-C12烷基或Z可选择性地被1至3个取代基取代，这些取代基可以相同也可以不同，选自由D、E组成的群，其中每个D独立地选自由三氟甲基、三氟甲氧基和C1-C4烷氧基组成的群；每个E独立地选自由卤素、羟基和C1-C8烷基组成的群；R3和R4选自由氢、C1-C4烷基和(CH2)y-苯基组成的群，其中y是0-8的整数，但R3和R4不能同时为氢；R5为C1-C8烷基；R1选自由环戊基、环戊烯基和异丙基组成的群，以及其药学上可接受的盐、光学异构体和水合物，但当R2为n为1或更大的群时，R1为异丙基或环戊基；R6为氢、C1-C4烷基或(CH2)m-苯基；Z为苯基、杂环或环烷基，Z被1至3个取代基取代，这些取代基可以相同也可以不同，选自由此外，本发明还提供了一种抑制细胞周期依赖性激酶，特别是cdk-2的方法。本发明还提供了一种预防神经元细胞凋亡和抑制肿瘤发展的方法。
• 一种二氧化碳促进和无光催化剂光诱导合成吲唑啉酮类化合物制备方法
  申请人：湖南大学

  公开号：CN109734666B

  公开（公告）日：2023-03-28

  本发明以喹啉2‑硝基苯甲醇类化合物、胺类衍生物为原料，以廉价、易得的普通灯泡作为反应的光源，以二氧化碳为促进剂，以常用的有机溶剂作反应溶剂，反应在一定温度下反应一定时间，高产率、高选择性地得到吲唑啉酮类化合物，并且在克级放大反应中得到很高的产率。